Novel Gene-Therapy Approach for Glaucoma
Simon John, PhD Columbia University
Co-Principal InvestigatorsKrish Kizhatil, PhD The Jackson Laboratory
The project aims to develop and test resources for Schlemm’s canal specific targeting and expression of genes for gene therapy. Successful development of this targeted therapy will help control eye pressure more effectively and provide better treatment options for glaucoma patients.